Agendia to Present Five Posters Demonstrating the Expanding Clinical Utility of MammaPrint + BluePrint at the 2025 San Antonio Breast Cancer Symposium.
News
- Agendia to Present Five Posters Demonstrating the Expanding Clinical Utility of ... - Yahoo Finance
- Aurinia: Q3 Earnings Snapshot | kens5.com
The biotechnology company posted revenue of $73.5 million in the period, beating Street forecasts. ... Download the San Antonio News from KENS 5 App.
- 22nd Century: Q3 Earnings Snapshot | kens5.com
The plant biotechnology company posted revenue of $4 million in the period. ... Download the San Antonio News from KENS 5 App. Download on the App Store ...
- Scilex Holding Company Announces Worldwide Exclusive License for Tokenization and ...
... biotech and biopharma industry, specifically enabling the creation ... 960 San Antonio Road Palo Alto, CA 94303. Office: (650) 516-4310. Email ...
- Actinium Pharmaceuticals, Inc. to Highlight ATNM-400 Data in Hormone-Resistant ... - PR Newswire
... San Antonio Breast Cancer Symposium (SABCS) taking place December 10‑14 ... Actinium Pharmaceuticals, Inc. to Participate in the Stephens Biotechnology ...
